Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on June 3, 2025

Bitget Lists Bondex (BDXN) for Spot Trading
Victoria, Seychelles, June 3rd, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Bondex (BDXN), adding it to spot trading. Bondex is a Web3-powered professional network. Trading for the BDXN/USDT …
![[Latest] Global Automotive Panoramic Sunroof Market Size/Share Worth USD 48.78 Billion by 2034 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)](/images/pressrelease-small.png)
[Latest] Global Automotive Panoramic Sunroof Market Size/Share Worth USD 48.78 Billion by 2034 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
Austin, TX, USA, June 03, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Automotive Panoramic Sunroof Market Size, Trends and Insights By Vehicle Type (ICE Powered, Electric Powered Vehicle), By Product Type ( …

HashiCorp Expands Unified Lifecycle Management for Hybrid Cloud Operations
LONDON, June 03, 2025 (GLOBE NEWSWIRE) -- Today at HashiDays London, its first international user conference as an IBM company, HashiCorp unveiled the vision for partnering with IBM to shape the future of hybrid cloud automation. Despite widespread …

Oculis to Participate in Upcoming June Investor Conferences
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs …

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 Inhibitor for Rare Genetic Skin Diseases
Financing co-led by new investor BRM Group and existing investor Pontifax Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatment of three rare genetic skin diseases; Olmsted syndrome, severe keratoderma …

West Red Lake Gold Highlights Bulk Sample Learnings
VANCOUVER, British Columbia, June 03, 2025 (GLOBE NEWSWIRE) -- West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or “WRLG” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to report how learnings from the test mining and bulk sample program at …

CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
Lehi, June 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 3rd, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s immune system to fight cancer, today announced that two of its lead …

AI data-fabric Treefera secures $30 million in Series B funding to accelerate global expansion and meet demand for supply chain transparency
LONDON, UK, June 03, 2025 (GLOBE NEWSWIRE) -- Treefera, the leading AI-enabled data fabric for supply chain resilience, today announced that it has raised $30 million in Series B funding to drive product development and expansion across North America, APAC …

Bitget Lists FLOCK (FLOCK) in Innovation and AI Zone
Victoria, Seychelles, June 3rd, 2025, Chainwire Bitget, the leading global cryptocurrency exchange and Web3 company, has announced the listing of FLOCK (FLOCK) in its Innovation and AI Zone. Trading for the FLOCK/USDT pair commenced on 1 June 2025, 15:30 ( …

Soitec and PSMC collaborate on ultra-thin TLT technology for nm-scale 3D stacking
Soitec and PSMC collaborate on ultra-thin TLT technology for nm-scale 3D stacking Bernin (France), June 3, 2025 – Soitec (Euronext – Tech Leaders), a world leader in the design and production of innovative …

Soitec et PSMC collaborent sur une technologie TLT ultra-mince pour l'empilement 3D à l'échelle nanométrique
Soitec et PSMC collaborent sur une technologie TLT ultra-mince pour l'empilement 3D à l'échelle nanométrique Bernin (France), le 3 juin 2025 - Soitec (Euronext - Tech Leaders), un leader mondial de la conception et de la production de matériaux …

Life360 Announces Pricing of Upsized Convertible Senior Notes Offering
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), today announced the pricing of its offering of $275.0 million aggregate principal amount of 0.00% convertible senior notes due 2030 (the “ …

Viridien sets new seismic data acquisition standard with launch of Sercel Accel – the world’s first onshore drop node solution
Paris, France – June 3, 2025 Viridien has launched the Sercel Accel – the industry’s first onshore drop node solution – which will revolutionize land seismic data acquisition. Unveiled at the EAGE Annual Conference and Exhibition in Toulouse, France, Accel …

Viridien établit une nouvelle référence dans l’acquisition de données sismiques avec le lancement d’Accel de Sercel - la première solution de « drop node » terrestre au monde
Paris, France – le 3 juin 2025 Viridien a lancé Accel, la première solution « drop node » terrestre de l’industrie, développée par Sercel, qui promet de révolutionner l’acquisition de données sismiques à terre. Dévoilé lors de la Conférence et Exposition …

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
June 3, 2025 Amsterdam, the Netherlands – argenx (Euronext …

Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, the EU, and China in immune thrombocytopenia Paris, June 3, 2025. The US …

Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose Quatrième désignation de médicament orphelin pour le rilzabrutinib dans les maladies rares En cours d’examen réglementaire aux États-Unis, …

Addex Convenes Annual General Meeting 2025
Geneva, Switzerland, June 3, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that …

The Crisis of Care: Caily Confronts Caregiver Burnout with Launch of Comprehensive Digital Platform in Summer 2025
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches unprecedented levels across the United States, a new health tech startup, Caily, is stepping forward to address what experts are calling a growing public health emergency. The …